Variant report

Variant	esv3437918
Chromosome Location	chr21:44786624-44790922
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr21:44788945-44789337	GM12878	blood:	n/a	chr21:44789171-44789181 chr21:44789170-44789181
2	BATF	chr21:44788955-44789361	GM12878	blood:	n/a	chr21:44789171-44789181 chr21:44789170-44789181
3	BCL3	chr21:44788279-44789339	GM12878	blood:	n/a	chr21:44789174-44789183 chr21:44789173-44789182
4	BCL3	chr21:44788465-44789325	GM12878	blood:	n/a	chr21:44789174-44789183 chr21:44789173-44789182
5	BHLHE40	chr21:44790480-44790513	GM12878	blood:	n/a	n/a
6	BHLHE40	chr21:44788743-44789319	K562	blood:	n/a	n/a
7	BHLHE40	chr21:44789947-44790181	GM12878	blood:	n/a	n/a
8	BHLHE40	chr21:44789015-44789315	HepG2	liver:	n/a	n/a
9	BHLHE40	chr21:44788758-44789362	GM12878	blood:	n/a	chr21:44789333-44789349
10	CEBPB	chr21:44789066-44789365	IMR90	lung:	n/a	n/a
11	CEBPB	chr21:44789105-44789302	A549	lung:	n/a	n/a
12	CEBPB	chr21:44789144-44789282	HepG2	liver:	n/a	n/a
13	CHD1	chr21:44789020-44789283	GM12878	blood:	n/a	n/a
14	CHD2	chr21:44788665-44789321	GM12878	blood:	n/a	n/a
15	CREB1	chr21:44789022-44789315	A549	lung:	n/a	n/a
16	CTCF	chr21:44790374-44790438	GM12878	blood:	n/a	n/a
17	CTCF	chr21:44788829-44788862	MCF-7	breast:	n/a	n/a
18	CTCF	chr21:44788920-44789070	HBMEC	blood vessel:	n/a	n/a
19	CTCF	chr21:44788631-44788745	MCF-7	breast:	n/a	n/a
20	CTCF	chr21:44788746-44788785	MCF-7	breast:	n/a	n/a
21	CTCF	chr21:44789118-44789157	NHEK	skin:	n/a	n/a
22	CTCF	chr21:44788817-44788888	MCF-7	breast:	n/a	n/a
23	CTCF	chr21:44788724-44788737	GM19238	blood:	n/a	n/a
24	CTCF	chr21:44788796-44788806	Fibrobl	skin:	n/a	n/a
25	CTCF	chr21:44788636-44788732	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr21:44788820-44788827	GM12891	blood:	n/a	n/a
27	CTCF	chr21:44788812-44788838	Fibrobl	skin:	n/a	n/a
28	CTCF	chr21:44789820-44789970	HAc	cerebellar:	n/a	n/a
29	CTCF	chr21:44788629-44788919	GM19239	blood:	n/a	n/a
30	CTCF	chr21:44789102-44789171	GM12878	blood:	n/a	n/a
31	CTCF	chr21:44788775-44788897	GM12892	blood:	n/a	n/a
32	CUX1	chr21:44789071-44789225	GM12878	blood:	n/a	n/a
33	EBF1	chr21:44790244-44790621	GM12878	blood:	n/a	chr21:44790440-44790449 chr21:44790438-44790449
34	EBF1	chr21:44790211-44790651	GM12878	blood:	n/a	chr21:44790440-44790449 chr21:44790438-44790449
35	EBF1	chr21:44788928-44789361	GM12878	blood:	n/a	n/a
36	EBF1	chr21:44787670-44788011	GM12878	blood:	n/a	chr21:44787860-44787873 chr21:44787862-44787871
37	EBF1	chr21:44787684-44787966	GM12878	blood:	n/a	chr21:44787860-44787873 chr21:44787862-44787871
38	EBF1	chr21:44788928-44789393	GM12878	blood:	n/a	n/a
39	EBF1	chr21:44787669-44788685	GM12878	blood:	n/a	chr21:44788472-44788483 chr21:44787860-44787873 chr21:44787862-44787871
40	ELF1	chr21:44789001-44789872	GM12878	blood:	n/a	n/a
41	EP300	chr21:44789042-44789257	GM12878	blood:	n/a	chr21:44789173-44789182 chr21:44789174-44789183
42	EP300	chr21:44787269-44787518	SK-N-SH_RA	brain:	n/a	n/a
43	EP300	chr21:44790128-44790385	SK-N-SH_RA	brain:	n/a	n/a
44	EP300	chr21:44788992-44789398	GM12878	blood:	n/a	chr21:44789173-44789182 chr21:44789174-44789183
45	EP300	chr21:44790429-44790489	GM12878	blood:	n/a	n/a
46	EP300	chr21:44788948-44789326	GM12878	blood:	n/a	chr21:44789173-44789182 chr21:44789174-44789183
47	FOS	chr21:44790145-44790494	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr21:44789104-44789332	MCF10A-Er-Src	breast:	n/a	chr21:44789173-44789183 chr21:44789174-44789182 chr21:44789174-44789183 chr21:44789173-44789182 chr21:44789175-44789182 chr21:44789172-44789184
49	FOS	chr21:44790054-44790514	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr21:44790061-44790515	MCF10A-Er-Src	breast:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr21:44787865..44790312-chr21:44808214..44809942,2	MCF-7	breast:
2	chr21:44784945..44787524-chr21:44806309..44807951,2	MCF-7	breast:
3	chr21:44780314..44782548-chr21:44784562..44786888,3	MCF-7	breast:
4	chr21:44785083..44788037-chr21:44788095..44789736,2	MCF-7	breast:
5	chr21:44785083..44788037-chr21:44788095..44789736,2	MCF-7	breast:
6	chr21:44776523..44779015-chr21:44786732..44788307,2	MCF-7	breast:
7	chr21:44788113..44790073-chr21:44844727..44846264,2	MCF-7	breast:
8	chr21:44781106..44783357-chr21:44784005..44786797,3	K562	blood:
9	chr21:44788189..44792112-chr21:44793177..44796400,4	MCF-7	breast:
10	chr21:44782808..44785727-chr21:44787853..44790103,2	K562	blood:
11	chr21:44781079..44785202-chr21:44785903..44790540,5	MCF-7	breast:
12	chr21:44778477..44780291-chr21:44788253..44791187,2	K562	blood:
13	chr21:44786597..44791011-chr21:44796414..44799261,3	MCF-7	breast:
14	chr21:44787122..44790843-chr21:44793154..44798480,6	K562	blood:

Variant related genes	Relation type
ENSG00000237989	TF binding region
ENSG00000225637	chromatin interactions
ENSG00000237989	chromatin interactions

Extended variants
information (count: 222 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:222 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs369583061	chr21:44786673-44786674	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs556250628	chr21:44786685-44786686	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs373422490	chr21:44786701-44786702	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs539234199	chr21:44786702-44786703	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs188001771	chr21:44786704-44786705	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs554150985	chr21:44786715-44786716	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs557459307	chr21:44786719-44786720	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs572662421	chr21:44786735-44786736	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs191141764	chr21:44786781-44786782	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs558284305	chr21:44786783-44786784	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs151186407	chr21:44786800-44786801	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs544314907	chr21:44786805-44786806	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs575784877	chr21:44786817-44786818	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs562620390	chr21:44786836-44786837	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs529693067	chr21:44786837-44786838	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs183446088	chr21:44786860-44786861	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs666699	chr21:44786863-44786864	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs527557763	chr21:44786869-44786870	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs552193793	chr21:44786870-44786871	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs570587444	chr21:44786888-44786889	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs531444635	chr21:44786922-44786923	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs549839402	chr21:44786938-44786939	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs666249	chr21:44786963-44786964	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs373449770	chr21:44786982-44786983	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs554105079	chr21:44786993-44786994	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs187355127	chr21:44786997-44786998	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs565942317	chr21:44787002-44787003	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs540084569	chr21:44787004-44787005	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs540628777	chr21:44787008-44787009	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs192183945	chr21:44787115-44787116	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs140346368	chr21:44787130-44787131	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs576706710	chr21:44787131-44787132	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs537670301	chr21:44787216-44787217	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs376773694	chr21:44787230-44787231	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs556279631	chr21:44787233-44787234	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs574550645	chr21:44787242-44787243	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs541585170	chr21:44787273-44787274	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs560050016	chr21:44787305-44787306	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs560373882	chr21:44787307-44787308	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs9975971	chr21:44787311-44787312	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs574135680	chr21:44787318-44787319	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs573234267	chr21:44787349-44787350	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs540107148	chr21:44787356-44787357	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs565194033	chr21:44787357-44787358	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs531385622	chr21:44787401-44787402	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs77730353	chr21:44787428-44787429	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs561565408	chr21:44787485-44787486	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs184768566	chr21:44787536-44787537	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs547584783	chr21:44787543-44787544	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs653435	chr21:44787553-44787554	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Prostate cancer	18632612	CNVD
Neuroblastoma	20406844	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:190 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:44777400-44788600	Enhancers	Fetal Brain Male	brain
2	chr21:44780200-44788400	Enhancers	Spleen	Spleen
3	chr21:44782200-44791600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr21:44782400-44789800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr21:44782600-44787000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr21:44782600-44787000	Weak transcription	Brain Substantia Nigra	brain
7	chr21:44782600-44787800	Enhancers	Fetal Muscle Leg	muscle
8	chr21:44782600-44788800	Weak transcription	Placenta Amnion	Placenta Amnion
9	chr21:44782600-44790400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr21:44782800-44787200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr21:44782800-44788600	Weak transcription	H9 Cell Line	embryonic stem cell
12	chr21:44782800-44790000	Weak transcription	HUES6 Cell Line	embryonic stem cell
13	chr21:44783000-44788800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr21:44783000-44789000	Weak transcription	HMEC	breast
15	chr21:44783000-44790000	Weak transcription	H1 Cell Line	embryonic stem cell
16	chr21:44783200-44786800	Weak transcription	Fetal Lung	lung
17	chr21:44783400-44788600	Weak transcription	Esophagus	oesophagus
18	chr21:44783800-44788200	Weak transcription	GM12878-XiMat	blood
19	chr21:44784200-44788200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
20	chr21:44784200-44788800	Weak transcription	Primary B cells from peripheral blood	blood
21	chr21:44784800-44789000	Enhancers	Brain Germinal Matrix	brain
22	chr21:44784800-44791400	Enhancers	Breast Myoepithelial Primary Cells	Breast
23	chr21:44785000-44789600	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr21:44785200-44786800	Enhancers	Left Ventricle	heart
25	chr21:44785200-44791000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
26	chr21:44785400-44788600	Enhancers	Brain Anterior Caudate	brain
27	chr21:44785400-44788600	Weak transcription	Gastric	stomach
28	chr21:44785400-44789400	Weak transcription	Fetal Thymus	thymus
29	chr21:44785600-44790400	Weak transcription	Fetal Intestine Large	intestine
30	chr21:44785600-44790800	Enhancers	Brain Angular Gyrus	brain
31	chr21:44785800-44790000	Weak transcription	Right Atrium	heart
32	chr21:44786000-44786800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr21:44786000-44790800	Enhancers	Brain Cingulate Gyrus	brain
34	chr21:44786200-44786800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr21:44786200-44786800	Enhancers	Fetal Brain Female	brain
36	chr21:44786200-44787200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
37	chr21:44786200-44788600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr21:44786200-44788600	Weak transcription	Fetal Heart	heart
39	chr21:44786200-44789400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr21:44786200-44790400	Weak transcription	Fetal Intestine Small	intestine
41	chr21:44786200-44791200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
42	chr21:44786400-44786800	Weak transcription	Brain Hippocampus Middle	brain
43	chr21:44786400-44789000	Enhancers	Brain Inferior Temporal Lobe	brain
44	chr21:44786600-44786800	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr21:44786800-44787000	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr21:44786800-44787000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr21:44786800-44787800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr21:44786800-44787800	Enhancers	Fetal Lung	lung
49	chr21:44786800-44788000	Weak transcription	Fetal Brain Female	brain
50	chr21:44786800-44788800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links